NCT00158327|CompletedPhase 3
Telephone-Based Care Management Program for Individuals With Anxiety Disorders
The RELAX Trial: Reducing Limitations From Anxiety in Primary Care
Loading search results
The RELAX Trial: Reducing Limitations From Anxiety in Primary Care
Sponsor study identifier
NIH
Secondary identifiers
interventional
360
1 country
1
Study Start
March 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2010
Actual (reported)Study Completion
February 2011
Actual (reported)This study will determine the impact of a telephone-based care management program for primary care patients with panic disorder or generalized anxiety disorder.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2011
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2004
Date type not reportedThis date has not been verified as actual or estimated.
September 7, 2005
Actual (reported)September 12, 2005
Actual (reported)June 2010
Actual (reported)February 2011
Actual (reported)Health-related quality of life (SF-36 MCS)
Measured at Month 12
Generalized anxiety symptoms
Measured at Month 12
Panic disorder severity scale (PDSS)
Measured at Month 12
PHQ-9
Measured at Month 12
Alcohol use
Measured at Month 12
Health services utilization
Measured at Month 12
Participants will receive telephone-based collaborative care
Participants will receive usual care
Participants assigned to the telephone-based program will have a choice of what type of treatment they will receive. The choices will include pharmacotherapy, workbook training designed to help participants improve their coping skills, referral to a community mental health specialist, or some combination of these treatments. Participants will receive telephone calls one to two times every month for 12 months. During the calls, participants will be asked about their attitude toward and adherence to their treatment regimen. They will also be asked about recent episodes of anxiety they have experienced and what coping techniques they have used.
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Rollman BL, Herbeck Belnap B, Reynolds CF, Schulberg HC, Shear MK. A contemporary protocol to assist primary care physicians in the treatment of panic and generalized anxiety disorders. Gen Hosp Psychiatry. 2003 Mar-Apr;25(2):74-82. doi: 10.1016/s0163-8343(03)00004-5.
Behringer T, Rollman BL, Herbeck-Belnap B, Houck PR, Mazumdar S, Schwarz EB. Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxiety. Prim Care Companion CNS Disord. 2011;13(2):PCC.10m01028. doi: 10.4088/PCC.10m01028.
Bruce L. Rollman, MD
University of Pittsburgh
First Submitted
September 7, 2005
First Posted
September 12, 2005
Study Start
March 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2010
Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome
Usual care may include one or more of several different treatments such as pharmacotherapy and cognitive behavioral therapy; the treatments will be chosen by participants' physicians and will be delivered for 12 months.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Rollman BL, Fischer GS, Zhu F, Belnap BH. Comparison of electronic physician prompts versus waitroom case-finding on clinical trial enrollment. J Gen Intern Med. 2008 Apr;23(4):447-50. doi: 10.1007/s11606-007-0449-0.
Study Completion
February 2011
Actual (reported)Last Updated
January 22, 2014
Record last verified: 2014-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: